KR940019294A - 비피복 정제 및 이의 제조방법 - Google Patents

비피복 정제 및 이의 제조방법 Download PDF

Info

Publication number
KR940019294A
KR940019294A KR1019940002475A KR19940002475A KR940019294A KR 940019294 A KR940019294 A KR 940019294A KR 1019940002475 A KR1019940002475 A KR 1019940002475A KR 19940002475 A KR19940002475 A KR 19940002475A KR 940019294 A KR940019294 A KR 940019294A
Authority
KR
South Korea
Prior art keywords
uncoated tablet
phase material
weight
low melting
tableting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019940002475A
Other languages
English (en)
Korean (ko)
Inventor
히로시 마또바
히로요시 고야마
주니찌 기구따
Original Assignee
다께다 구니오
다께다야꾸힝고오교 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다께다 구니오, 다께다야꾸힝고오교 가부시끼가이샤 filed Critical 다께다 구니오
Publication of KR940019294A publication Critical patent/KR940019294A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
    • F04C2210/00—Fluid
    • F04C2210/26—Refrigerants with particular properties, e.g. HFC-134a

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019940002475A 1993-02-10 1994-02-08 비피복 정제 및 이의 제조방법 Ceased KR940019294A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP93-45958 1993-02-10
JP4595893 1993-02-10

Publications (1)

Publication Number Publication Date
KR940019294A true KR940019294A (ko) 1994-09-14

Family

ID=12733779

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940002475A Ceased KR940019294A (ko) 1993-02-10 1994-02-08 비피복 정제 및 이의 제조방법

Country Status (10)

Country Link
US (1) US5456920A (cg-RX-API-DMAC10.html)
EP (1) EP0610854B1 (cg-RX-API-DMAC10.html)
KR (1) KR940019294A (cg-RX-API-DMAC10.html)
CN (1) CN1106652A (cg-RX-API-DMAC10.html)
AT (1) ATE191846T1 (cg-RX-API-DMAC10.html)
CA (1) CA2115308C (cg-RX-API-DMAC10.html)
DE (1) DE69423990T2 (cg-RX-API-DMAC10.html)
FI (1) FI940585L (cg-RX-API-DMAC10.html)
NO (1) NO940373L (cg-RX-API-DMAC10.html)
TW (1) TW272942B (cg-RX-API-DMAC10.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331839T2 (de) * 1992-01-29 2002-12-12 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
TW466119B (en) * 1994-02-28 2001-12-01 Janssen Pharmaceutica Nv Film coated tablet of paracetamol and domperidone
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
CN1220598A (zh) * 1996-05-02 1999-06-23 大正制药株式会社 水难溶性酸性药物的悬浮液
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
AU1234399A (en) * 1997-11-25 1999-06-15 Bayer Aktiengesellschaft Sustained release formulations comprising alpha-glucosidase-i nhibitors
WO1999050217A1 (en) * 1998-03-31 1999-10-07 Bayer Aktiengesellschaft Valiolone, a method of preparing it, and its use to prepare acarbose and voglibose
CH689452C1 (de) * 1998-04-15 2004-11-30 Marcel Christian Wegmueller Verfahren zur Verhinderung von zementbedingten ablagerungen in einem Bauwerksentwaesserungssystem.
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ES2377847T3 (es) 1999-01-13 2012-04-02 Bayer Healthcare Llc Difenil ureas sustituidas con omega-carboxi arilo como agentes inhibidores de la cinasa p38
DE60039379D1 (de) * 1999-02-10 2008-08-21 Pfizer Prod Inc Pharmazeutische feste Dispersionen
US20020071864A1 (en) * 1999-03-25 2002-06-13 Yuhan Corporation Rapidly disintegrable tablet for oral administration
CA2376202C (en) * 1999-06-07 2008-11-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel preparation and administration form comprising an acid-labile active compound
WO2001015665A1 (en) 1999-09-02 2001-03-08 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
US20070059367A1 (en) * 2000-06-06 2007-03-15 Cherukuri S R Drug Delivery System and Associated Methods
US20100196466A1 (en) * 2000-06-06 2010-08-05 Capricorn Pharma Inc. Drug delivery system
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US6660292B2 (en) * 2001-06-19 2003-12-09 Hf Flavoring Technology Llp Rapidly disintegrating flavored film for precooked foods
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
CN1596104A (zh) 2001-09-28 2005-03-16 麦克内尔-Ppc股份有限公司 改进的释放剂型
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
EP1478358B1 (en) 2002-02-11 2013-07-03 Bayer HealthCare LLC Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
US7011688B2 (en) * 2002-05-10 2006-03-14 C.R. Bard, Inc. Prosthetic repair fabric
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
WO2004093850A1 (en) * 2003-04-24 2004-11-04 Jagotec Ag Tablet with coloured core
ES2288694T3 (es) 2003-05-20 2008-01-16 Bayer Pharmaceuticals Corporation Diaril ureas para enfermedades mediadas por el receptor del factor de crecimiento derivado de plaquetas.
KR101139557B1 (ko) 2003-07-23 2012-04-30 바이엘 파마슈티칼스 코포레이션 질환 및 상태의 치료 및 예방을 위한 플루오로 치환오메가-카르복시아릴 디페닐 우레아
FR2862187B1 (fr) * 2003-11-19 2006-02-24 Sbm Dev Nouvelles compositions agrochimiques et leur procede de fabrication
FR2867025B1 (fr) * 2004-03-05 2006-06-02 Sbm Dev Compositions agrochimiques solides a desagregation rapide
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
DE102005028696A1 (de) * 2005-06-21 2006-12-28 Pulmotec Gmbh Verwendung eines Hilfsstoffs zur Einstellung der Abrasionsfestigkeit eines verfestigten Wirkstoffpräparats
PT2049123E (pt) 2006-08-03 2013-03-06 Horizon Pharma Ag Tratamento de doença reumatóide com glucocorticóide de libertação retardada
TW200829286A (en) * 2006-09-06 2008-07-16 Genzyme Corp Polystyrene sulfonate polymer tablets, their preparation and use
DE602007011792D1 (de) * 2006-10-27 2011-02-17 Fmc Corp Gemeinsam aufbereitete mikrokristalline cellulose und zuckeralkohol als hilfsstoff für tablettenformulierungen
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
EP3811371A1 (en) 2018-06-21 2021-04-28 Aquestive Therapeutics, Inc. System and method for making personalized individual unit doses containing pharmaceutical actives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070127A3 (en) * 1981-07-10 1983-08-17 Beecham Group Plc Tablets
JPH01308231A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 安定化された医薬組成物および製造法
JPH0425926A (ja) * 1990-05-22 1992-01-29 Toshiba Corp 情報処理装置
TW284688B (cg-RX-API-DMAC10.html) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
FI940585A7 (fi) 1994-08-11
FI940585A0 (fi) 1994-02-09
NO940373D0 (no) 1994-02-04
DE69423990D1 (de) 2000-05-25
EP0610854A1 (en) 1994-08-17
EP0610854B1 (en) 2000-04-19
TW272942B (cg-RX-API-DMAC10.html) 1996-03-21
DE69423990T2 (de) 2000-08-17
US5456920A (en) 1995-10-10
CA2115308C (en) 2004-05-11
NO940373L (no) 1994-08-11
CA2115308A1 (en) 1994-08-11
ATE191846T1 (de) 2000-05-15
FI940585L (fi) 1994-08-11
CN1106652A (zh) 1995-08-16

Similar Documents

Publication Publication Date Title
KR940019294A (ko) 비피복 정제 및 이의 제조방법
WO1999037274A3 (en) Dry emollient compositions
UA35559C2 (uk) Фармацевтична композиція, продукт трансетерифікації кукурудзяної олії гліцерином та спосіб його одержання
EP2465487A2 (en) Propylene glycol/glycerin-based deodorant
EP0392608A3 (en) Solid consumer product compositions containing small particle cyclodextrin complexes
WO2002098230A3 (de) Verwendung von fettalkoholethoxylaten als penetrationsförderer
EP0400910A3 (en) Shaped articles containing liquefiable powders for delivery of cosmetic and other personal care agents
EP0659403B1 (en) Use of oil adsorbent natural polymer for cosmetic and pharmaceutical applications
EP0113930B1 (en) Improved compressing aid for compressing powders
US4347235A (en) Water-soluble tablet
US4591502A (en) Compressing aid for cosmetic powders
EP4674403A1 (en) Anti-bacterial and sunscreen solid-blocky powder composition having ornament component and preparation method therefor
KR102861153B1 (ko) 구상 파우더를 포함하는 색조 화장료 조성물
RU97114578A (ru) Биологически активная добавка к пище "коррида" для отвыкания от курения
US6143285A (en) Body powder composition
JPS62120301A (ja) 改良された農薬粉剤
KR20150017142A (ko) 성형성을 향상시킨 파우더 조성물의 제조 방법
CA2105873A1 (en) A topical soap gel preparation
JPH04230317A (ja) 乳液状組成物
JP2014091714A (ja) 錠剤用粉粒体および錠剤
KR900701254A (ko) 정제 가능한 제제 및 이것으로 만들어진 정제
JPH044299B2 (cg-RX-API-DMAC10.html)
RU1829888C (ru) Состав дл хранени плодоовощной продукции
JP5162157B2 (ja) 親油性成分含有粉末
JPH119201A (ja) プロポリス粉末及びその製造方法

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000